Parkinson's Disease clinical trials
Showing 151–200 of 314 active trials. Describe your situation to see which ones look like a fit.
- A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease
- University of Delaware Parkinson's Disease Registry
- The GBA Multimodal Study in Parkinson's Disease
- Investigations of Dementia in Parkinson Disease
- Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- The Parkinson's Genetic Research Study
- Moving Yourself in Space and Time: MYSTIC
- GBPDC: Gut-Brain in PD Consortium Master Protocol
- Intestinal Immunity in Neurologic Disease
- Natural History Protocol for Movement Disorders
- Parkinson's Disease Biomarkers in Nerve Cells in the Gut
- Parkinson's Disease and Movement Disorders Clinical Database
- PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Autoimmune Features of Neurodegenerative Disorders
- Abbott DBS Post-Market Study of Outcomes for Indications Over Time
- Clinical Outcomes for Deep Brain Stimulation
- Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging
- Deep Brain Stimulation (DBS) Retrospective Outcomes Study
- Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NYSCF Scientific Discovery Biobank
- UPenn Observational Research Repository on Neurodegenerative Disease
- Longitudinal Cognitive Assessment by BoCA
- Retinal Imaging in Neurodegenerative Disease
- Modifiable Variables in Parkinsonism (MVP)
- Natural History Study of Synucleinopathies
- Physiological Brain Atlas Development
- Evaluation and Treatment of Neurosurgical Disorders
- Apathy in Parkinson Disease TMS Study
- Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease
- Efficacy of a Breathwork Practice (SKY) on Well-Being of Individuals With Parkinson's Disease (iPD) and Care Partners
- Neocortical Microarchitecture of Executive Function
- Motor Network Physiology
- Safety and Tolerability of Patterned Stimulation for DBS in the Home Setting
- Blood Flow Restriction for Optimizing Balance in Parkinson's Disease
- Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)
- Zesty Exercise System for Therapeutic Engagement
- SegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease
- Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients
- Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.
- Percept Transitions in FOG and PD
- Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease
- Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control
- Corticostriatal Contributions to Parkinson's Disease Cognitive Impairment
- Accelerated TMS for Freezing of Gait in Parkinson's Disease
- Dance and Energy Expenditure Among Adults With Parkinson's
- Evaluation of a Decision Aid for Deep Brain Stimulation Surgery for Parkinson's Disease
- Deep Brain Stimulation Neural Recordings of Varied Stimulation During Sleep in Parkinson's Disease
- High Frequency Light, Sound, and Tactile Stimulation to Improve Motor and Cognitive Deficits in Parkinson's Disease
- Speech Learning and Speech Production in Parkinson's Disease
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.